About Medicago 021 Subject App
Application in support of vaccine in clinical trials to determine safety for use in humans. eDiary collects signs and symptoms of reactions for seven days after the injection and reports data to study investigators. Study...
Application in support of vaccine in clinical trials to determine safety for use in humans. eDiary collects signs and symptoms of reactions for seven days after the injection and reports data to study investigators. Study participants will receive notification reminders to complete their daily eDiary. Access to participate in this study requires informed consent by medical personnel. Only after consenting will participants receive an invitation to complete eDiaries. snapIoT and its platforms are HIPAA, California Privacy Rights Act, and GDPR compliant
Previous Versions
Here you can find the changelog of Medicago 021 Subject App since it was posted on our website on 2020-12-19 07:03:06.
The latest version is 1.1.7 and it was updated on 2024-04-22 11:56:08. See below the changes in each version.
Medicago 021 Subject App version 1.1.7
Updated At: 2020-12-14
Changes: - Bug fixes
Disclaimer
Official Google Play Link
We do not host Medicago 021 Subject App on our servers. We did not scan it for viruses, adware, spyware or other type of malware. This app is hosted by Google and passed their terms and conditions to be listed there. We recommend caution when installing it.
The Google Play link for Medicago 021 Subject App is provided to you by apps112.com without any warranties, representations or guarantees of any kind, so access it at your own risk.
If you have questions regarding this particular app contact the publisher directly. For questions about the functionalities of apps112.com contact us.
